Daré Bioscience (DARE) Competitors $2.88 -0.03 (-1.00%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DARE vs. ALEC, MCRB, ENTA, FTLF, XBIT, CHRS, SLS, CCCC, BHST, and OPTNShould you be buying Daré Bioscience stock or one of its competitors? The main competitors of Daré Bioscience include Alector (ALEC), Seres Therapeutics (MCRB), Enanta Pharmaceuticals (ENTA), FitLife Brands (FTLF), XBiotech (XBIT), Coherus BioSciences (CHRS), SELLAS Life Sciences Group (SLS), C4 Therapeutics (CCCC), BioHarvest Sciences (BHST), and OptiNose (OPTN). These companies are all part of the "pharmaceutical products" industry. Daré Bioscience vs. Alector Seres Therapeutics Enanta Pharmaceuticals FitLife Brands XBiotech Coherus BioSciences SELLAS Life Sciences Group C4 Therapeutics BioHarvest Sciences OptiNose Alector (NASDAQ:ALEC) and Daré Bioscience (NASDAQ:DARE) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, community ranking, analyst recommendations, risk and earnings. Do institutionals & insiders believe in ALEC or DARE? 85.8% of Alector shares are held by institutional investors. Comparatively, 6.7% of Daré Bioscience shares are held by institutional investors. 9.1% of Alector shares are held by company insiders. Comparatively, 4.0% of Daré Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to ALEC or DARE? In the previous week, Alector had 1 more articles in the media than Daré Bioscience. MarketBeat recorded 3 mentions for Alector and 2 mentions for Daré Bioscience. Daré Bioscience's average media sentiment score of 0.20 beat Alector's score of 0.00 indicating that Daré Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alector 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Daré Bioscience 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, ALEC or DARE? Daré Bioscience has lower revenue, but higher earnings than Alector. Daré Bioscience is trading at a lower price-to-earnings ratio than Alector, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlector$100.56M0.91-$130.39M-$1.23-0.75Daré Bioscience$9.78K2,623.16-$30.16M-$0.51-5.69 Do analysts rate ALEC or DARE? Alector currently has a consensus price target of $3.50, suggesting a potential upside of 280.39%. Daré Bioscience has a consensus price target of $24.00, suggesting a potential upside of 727.59%. Given Daré Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Daré Bioscience is more favorable than Alector.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alector 2 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.14Daré Bioscience 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is ALEC or DARE more profitable? Daré Bioscience has a net margin of -191.65% compared to Alector's net margin of -257.54%. Daré Bioscience's return on equity of 0.00% beat Alector's return on equity.Company Net Margins Return on Equity Return on Assets Alector-257.54% -108.77% -27.03% Daré Bioscience -191.65%N/A -18.98% Which has more volatility & risk, ALEC or DARE? Alector has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Daré Bioscience has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Does the MarketBeat Community favor ALEC or DARE? Daré Bioscience received 202 more outperform votes than Alector when rated by MarketBeat users. Likewise, 73.36% of users gave Daré Bioscience an outperform vote while only 60.94% of users gave Alector an outperform vote. CompanyUnderperformOutperformAlectorOutperform Votes15660.94% Underperform Votes10039.06% Daré BioscienceOutperform Votes35873.36% Underperform Votes13026.64% SummaryDaré Bioscience beats Alector on 12 of the 18 factors compared between the two stocks. Get Daré Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DARE vs. The Competition Export to ExcelMetricDaré BiosciencePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.67M$6.45B$5.30B$7.34BDividend YieldN/A3.23%5.12%4.30%P/E Ratio-4.916.8921.8017.77Price / Sales2,623.16231.02379.9097.68Price / CashN/A65.6738.2634.64Price / Book-4.755.916.443.98Net Income-$30.16M$142.72M$3.21B$247.52M7 Day Performance-1.36%4.35%2.84%1.82%1 Month Performance-2.36%-12.79%-8.65%-6.98%1 Year Performance-18.11%-9.70%11.38%1.49% Daré Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DAREDaré Bioscience1.9394 of 5 stars$2.90-0.3%$24.00+727.6%-14.5%$25.67M$9,784.00-4.9130Short Interest ↓News CoverageALECAlector3.0794 of 5 stars$1.01-1.0%$3.50+246.5%-81.9%$100.08M$100.56M-0.59270News CoverageMCRBSeres Therapeutics3.0378 of 5 stars$0.57-10.6%$4.00+598.8%-41.0%$99.80M$126.33M-2.49330News CoverageGap UpENTAEnanta Pharmaceuticals4.0353 of 5 stars$4.64-1.9%$17.25+271.8%-63.6%$98.99M$66.59M-0.94160Positive NewsGap DownFTLFFitLife Brands4.2379 of 5 stars$10.47+0.7%$20.50+95.8%-9.9%$96.52M$64.47M12.3920Positive NewsGap UpHigh Trading VolumeXBITXBiotech0.8249 of 5 stars$3.15+9.8%N/A-63.7%$96.04M$4.01M-2.92100Positive NewsGap DownCHRSCoherus BioSciences3.621 of 5 stars$0.82+5.1%$5.38+554.3%-47.9%$95.21M$266.96M-10.27330Analyst DowngradeNews CoverageSLSSELLAS Life Sciences Group0.1761 of 5 stars$1.04flatN/A-7.8%$94.48M$1M-1.5110CCCCC4 Therapeutics2.4695 of 5 stars$1.33+1.5%$12.50+839.8%-81.8%$94.42M$35.58M-0.78150News CoverageBHSTBioHarvest SciencesN/A$5.60+1.1%$13.00+132.1%N/A$91.98M$25.19M-4.48N/APositive NewsOPTNOptiNose3.2933 of 5 stars$9.10flat$9.00-1.1%-40.1%$91.66M$78.23M-2.17190Short Interest ↓Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Alector Alternatives Seres Therapeutics Alternatives Enanta Pharmaceuticals Alternatives FitLife Brands Alternatives XBiotech Alternatives Coherus BioSciences Alternatives SELLAS Life Sciences Group Alternatives C4 Therapeutics Alternatives BioHarvest Sciences Alternatives OptiNose Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DARE) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DARE Stock Free DARE Stock Alerts